Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Capecitabine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00689702
What this trial is testing

Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
Institute of Oncology Ljubljana 43
Large-scale testing (Phase 3)Study completedNCT00009737
What this trial is testing

Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 1,987
Testing effectiveness (Phase 2)Ended earlyNCT01042028
What this trial is testing

A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Per Pfeiffer 39
Early research (Phase 1)Study completedNCT00050167
What this trial is testing

Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 603
Testing effectiveness (Phase 2)Looking for participantsNCT03213002
What this trial is testing

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

Who this might be right for
Glioblastoma Multiforme (GBM)GlioblastomaGlioma of Brain+6 more
Northwell Health 67
Large-scale testing (Phase 3)UnknownNCT00440167
What this trial is testing

Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine

Who this might be right for
Pancreatic Cancer
PD Dr. med. Volker Heinemann 280
Large-scale testing (Phase 3)Study completedNCT00078572
What this trial is testing

Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
GlaxoSmithKline 408
Testing effectiveness (Phase 2)UnknownNCT04083365
What this trial is testing

Capecitabine Plus Concomitant Radiation Therapy Followed by Durvalumab as Preoperative Treatment in Rectal Cancer

Who this might be right for
RECTAL CANCER
AUSL Romagna Rimini 100
Testing effectiveness (Phase 2)Study completedNCT02864849
What this trial is testing

Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer

Who this might be right for
Rectal Cancer
Peking University Cancer Hospital & Institute 81
Large-scale testing (Phase 3)Study completedNCT00766155
What this trial is testing

Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,094
Testing effectiveness (Phase 2)WithdrawnNCT00450515
What this trial is testing

Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Looking for participantsNCT05040360
What this trial is testing

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Who this might be right for
Metastatic Malignant Neoplasm in the LiverPancreatic Neuroendocrine TumorStage I Pancreatic Neuroendocrine Tumor AJCC v8+2 more
SWOG Cancer Research Network 141
Not applicableStudy completedNCT01487343
What this trial is testing

Patient Factors Impacting Adherence to Oral Chemotherapy

Who this might be right for
Breast CancerGastrointestinal Cancer
Memorial Sloan Kettering Cancer Center 79
Testing effectiveness (Phase 2)UnknownNCT05042791
What this trial is testing

Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases

Who this might be right for
HER2-positive Metastatic Breast Cancer
Jiangxi Provincial Cancer Hospital 362
Early research (Phase 1)Study completedNCT00353262
What this trial is testing

Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 36
Testing effectiveness (Phase 2)Study completedNCT00842491
What this trial is testing

Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Peking University 45
Testing effectiveness (Phase 2)UnknownNCT06458413
What this trial is testing

Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer

Who this might be right for
Breast Cancer Recurrent
Min Yan, MD 40
Testing effectiveness (Phase 2)UnknownNCT04394598
What this trial is testing

Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Fudan University 210
Testing effectiveness (Phase 2)Ended earlyNCT00881621
What this trial is testing

Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer

Who this might be right for
Pancreas Cancer
Georgetown University 17
Testing effectiveness (Phase 2)Study completedNCT01783444
What this trial is testing

A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 309
Next Page